Physician profile
Erin Flaherty
NPI 1609421932
$1,065.85
in general payments reported to CMS, 2019-2025
17 companies · $79.65 in 2025
The $79.65 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $530 · 2022: $78.10 · 2023: $298 · 2024: $80.61 · 2025: $79.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $90.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $236.16 | 2023-2025 | Opdivo |
| Daiichi Sankyo INC. | $125.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $124.54 | 2021 | |
| Epizyme, INC. | $122.10 | 2021 | |
| Amgen INC. | $90.84 | 2021 | |
| Acrotech Biopharma INC. | $90.20 | 2023 | Beleodaq |
| Janssen Biotech, INC. | $67.08 | 2021 | |
| Eisai INC. | $35.88 | 2023 | |
| Tempus Ai, INC | $30.41 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $24.63 | 2023 | Tazverik |
| Geron Corporation | $23.31 | 2025 | Rytelo |
| Incyte Corporation | $21.65 | 2022 | |
| Seagen INC. | $17.60 | 2023 | Adcetris |
| Lilly USA, LLC | $16.65 | 2022 | |
| Sobi, INC | $14.36 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $13.39 | 2022 | |
| Exelixis INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Flaherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.